Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CardioCell in Chronic Ischemic Heart Failure
NCT03418233Phase 3Completed
- Sponsor
- Krakowski Szpital Specjalistyczny im. Jana Pawła II
- Start
- Apr 2018
- Primary completion
- Jan 2021
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 3 trial of ischemia-tolerant mesenchymal stem cells in Ischemic Heart Failure (IHF), sponsored by Krakowski Szpital Specjalistyczny im. Jana Pawła II. Started Apr 2018; status: completed.
02
Drugs
ischemia-tolerant mesenchymal stem cells
03
Conditions
Ischemic Heart Failure (IHF)
Beyond the preview
Go deeper on NCT03418233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03418233.